Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06727578 · ClinicalTrials.gov registry record · NA
Pleural Irrigation With a Novel Devise.
A NA study of Pleural Effusion Disorder, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06727578 is a NA study of Pleural Effusion Disorder that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06727578, a NA study of Pleural Effusion Disorder, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-arm pilot trial of the use of intrapleural saline irrigation to treat retained pleural infections for patients with contraindications to standard of care intrapleural enzymatic therapy.
Conditions Studied
Interventions
- DEVICE of intrapleural saline irrigation with CLR irrigator
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-25 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06727578
The ClinicalTrials.gov registry entry for NCT06727578 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pleural Effusion Disorder appearing as the primary indexed condition, and to 1 intervention - of which of intrapleural saline irrigation with CLR irrigator is the first listed.
NCT06727578 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06727578 about?
NCT06727578 is a clinical study titled "Pleural Irrigation With a Novel Devise.". Single-arm pilot trial of the use of intrapleural saline irrigation to treat retained pleural infections for patients with contraindications to standard of care intrapleural enzymatic therapy.
What is the current status of trial NCT06727578?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-25. Estimated completion is 2026-07-31.
What conditions does trial NCT06727578 study?
This clinical trial studies the following conditions: Pleural Effusion Disorder.
What interventions are being tested in trial NCT06727578?
The interventions under investigation include: of intrapleural saline irrigation with CLR irrigator (DEVICE).
Who is sponsoring clinical trial NCT06727578?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06727578 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pleural Effusion Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.